Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic GEA eligible for ZIIHERA

Daiichi Sankyo and AstraZeneca launch phase 3 trial of Datroway in high-risk bladder cancer

Inify Laboratories launches UK operations with first NHS agreement

Senhwa completes enrolment in Phase 1b expansion trial of CX-5461

McKesson to acquire Precision Medicine Group for approximately USD2.25bn

BreakBio set to enter clinic

Astellas doses first patient in Phase 3 study of ASP2138

Gilead expands Trodelvy role in first-line metastatic triple-negative breast cancer in Europe

GSK's Jemperli wins FDA priority review for advanced rectal cancer

Anbogen Therapeutics enters collaborative research agreement with University of Tokyo for ABT-301 evaluation across multiple tumour types

Leads Biolabs NDA for Opamtistomig accepted by China's CDE

Ipsen completes Kartos Therapeutics acquisition, strengthening late-stage oncology pipeline

Nuvation Bio's safusidenib granted FDA Fast Track Designation for IDH1-mutant glioma treatment

Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance

Annexin Pharmaceuticals receives proposed INN vanexin for ANXV